Israel Englander Neurocrine Biosciences Inc Call Options Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding NBIX
# of Institutions
621Shares Held
95.4MCall Options Held
661KPut Options Held
221K-
Black Rock Inc. New York, NY14.2MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.26 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$577 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$309 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$296 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...